s6y
Company name or ticker
Search
Jounce Therapeutics, Inc.
10-K
Annual Report for period ending Dec 31, 2016
Filed
Friday, March 10, 2017
Period
Dec 31, 2016
Accession number
0001640455-17-000010
Documents
10-K
10-K
EXHIBIT 10.15
EX-10.15
EXHIBIT 23.1
EX-23.1
EXHIBIT 31.1
EX-31.1
EXHIBIT 31.2
EX-31.2
EXHIBIT 32.1
EX-32.1
On sec.gov
Filing index
All files
Complete submission text
SGML header